Stock Insider AIKnow. Analyze. Invest.
Johnson & Johnson logo

JNJ

Johnson & Johnson

HealthcareDrug Manufacturers$495B Market Cap

Pharmaceuticals, medical devices, consumer health products. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

SEC Form 4 FilingsStock Chart
Insider Sentiment
Based on recent trading activity
53%Neutral
Buy/Sell Ratio56% buys
BearishBullish

Insider Buys

8

$35.95M

Insider Sales

7

$28.70M

Total Volume

$64.64M

15 transactions

Net Activity

+$7.25M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
100Confidence

Sentiment Rating

Strong Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Moderate accumulation: purchases represent 56% of total transaction value.
  • •Cluster buying: 5 unique insiders purchased shares, showing strong alignment.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
  • •Ultra-high accumulation: total purchase value exceeds $10M.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
C
1

Chief Operating Officer

COO

3 buys0 sells

$16.22M total

V
2

VP Operations

VP

1 buys2 sells

$15.21M total

J
3

Joseph Wolk

CFO

2 buys1 sells

$14.33M total

J
4

Joaquin Duato

CEO

1 buys2 sells

$11.03M total

B
5

Board Director

Dir

1 buys2 sells

$7.86M total

Insider Trading Summary
Automated trend commentary

Over the last 90 days, corporate insiders at Johnson & Johnson (JNJ) engaged in a total of 15 transactions reported via SEC Form 4 filings. Among these, 8 were open-market purchases and 7 were sales. The total volume of insider trading reached $64.64M.

The net insider activity for JNJ shows a net buying bias of $7.25M. This activity represents a 56% buy ratio, suggesting that insiders are currently neutral on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Joaquin Duato (CEO), who traded 48.8K shares valued at $9.66M on Sep 26, 2026.

Quick Actions

Advanced ScreenerLatest TradesView Charts
Trading History
JNJ insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 26, 2026

2 days ago

Joaquin Duato

CEO

CEO
Sell48.8K$197.75$9.66M

Sep 17, 2026

1 weeks ago

Joaquin Duato

CEO

CEO
Buy3.6K$209.90$746K

Sep 16, 2026

1 weeks ago

Chief Operating Officer

COO

COO
Buy12.0K$197.15$2.38M

Sep 16, 2026

1 weeks ago

Board Director

Dir

Director
Sell7.5K$212.68$1.61M

Sep 14, 2026

2 weeks ago

VP Operations

VP

VP
Buy26.0K$211.97$5.50M

Sep 14, 2026

2 weeks ago

Joseph Wolk

CFO

CFO
Buy14.0K$198.11$2.78M

Sep 13, 2026

2 weeks ago

Joseph Wolk

CFO

CFO
Buy35.6K$199.32$7.10M

Sep 11, 2026

2 weeks ago

Joaquin Duato

CEO

CEO
Sell3.0K$211.30$628K

Sep 10, 2026

2 weeks ago

Board Director

Dir

Director
Sell13.1K$201.78$2.65M

Sep 9, 2026

2 weeks ago

Board Director

Dir

Director
Buy18.1K$198.97$3.60M

Sep 5, 2026

3 weeks ago

VP Operations

VP

VP
Sell39.0K$198.08$7.73M

Sep 3, 2026

3 weeks ago

VP Operations

VP

VP
Sell9.2K$214.18$1.98M

Sep 2, 2026

3 weeks ago

Joseph Wolk

CFO

CFO
Sell20.9K$212.65$4.45M

Aug 30, 2026

4 weeks ago

Chief Operating Officer

COO

COO
Buy31.0K$198.13$6.14M

Aug 31, 2026

4 weeks ago

Chief Operating Officer

COO

COO
Buy38.4K$200.91$7.71M

Explore Peers in Drug Manufacturers

Compare insider activity and sentiment scores across similar organizations.

Eli Lilly and Company logo

LLY

Eli Lilly and Company

AbbVie Inc. logo

ABBV

AbbVie Inc.

FAQs About Johnson & Johnson Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for JNJ.

Based on SEC Form 4 disclosures, the Insider Confidence Score for JNJ is currently 100/100, which reflects a strong accumulation bias. This calculation accounts for a total of 8 purchases and 7 sales by company executives over the last 90 days.

The CEO Conviction Index for JNJ is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.